Next-Generation Drug Discovery - An Initiative

A new collaboration brings together expertise in systems biology from the University of Cambridge (UK) and MIT (Cambridge, MA) to address urgent and severe bottlenecks in therapeutics discovery and development.

Dr Karen Smith, The Cambridge-MIT Institute's Next-Generation Drug Discovery Community (February 2005)

View full article    |    Back to Discovery Technology section